Literature DB >> 8326217

Hearing impairment and ear pathology in Nepal.

P Little1, A Bridges, R Guragain, D Friedman, R Prasad, N Weir.   

Abstract

A stratified random cluster sample of 15,845 subjects was performed in two regions of Nepal to determine the prevalence and main causes of hearing impairment (the most common disability) and the prevalence of ear disease. Subjects reporting current ear pain, or ear discharge, or hearing impairment on direct questioning by a Nepali health worker (primary screening failed), had otoscopy and audiometry (using the Liverpool Field Audiometer) performed, and a questionnaire administered relating to past history. In every fifth house subjects who passed the primary screening (1,716 subjects) were examined to assess the false negative rate of screening. An estimated 16.6 per cent of the study population have hearing impairment (either ear worse than 30 dB hearing threshold level (HTL) 1.0-4.0 kHz, or 50 dB HTL 0.5 kHz), and 7.4 per cent ear drum pathology, equivalent to respectively 2.71 and 1.48 million people extrapolated to the whole of Nepal. Most hearing impairment in the school age group (55.2 per cent) is associated with otitis media or its sequelae. Probably at least 14 per cent of sensorineural deafness is preventable (7 per cent infectious disease, 3.9 per cent trauma, 0.8 per cent noise exposure, 1 per cent cretinism, and 1 per cent abnormal pregnancy or labour). Most individuals reporting current ear pathology (61 per cent) had never attended a health post, and of those receiving ear drop treatment, 84 per cent still had serious pathology. Of subjects who reported ear drop treatment at any time, 31 per cent still had serious pathology. The use of traditional remedies was prevalent.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8326217     DOI: 10.1017/s0022215100123278

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  8 in total

1.  Designing of a digital behind-the-ear hearing aid to meet the World Health Organization requirements.

Authors:  Ricardo Ferreira Bento; Silvio Pires Penteado
Journal:  Trends Amplif       Date:  2010-06

2.  Hearing loss is associated with decreased nonverbal intelligence in rural Nepal.

Authors:  Susan D Emmett; Jane Schmitz; Joseph Pillion; Lee Wu; Subarna K Khatry; Sureshwar L Karna; Steven C LeClerq; Keith P West
Journal:  Otol Neurotol       Date:  2015-01       Impact factor: 2.311

3.  Pattern of Hearing Loss Among Patients Attending ENT Department of a Tertiary Hospital in Nepal: A Retrospective Study.

Authors:  Prakash Khanal; Shuvash Acharya; Nabin Lageju
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-01-21

4.  Chronic otitis media and subsequent hearing loss in children from the Himalayan region residing in Buddhist Monastic schools of Nepal.

Authors:  Milan Maharjan; Samjhana Phuyal; Mana Shrestha; Rosy Bajracharya
Journal:  J Otol       Date:  2020-09-04

5.  Community oriented research program for prevention of deafness with special stress on children - A preliminary report.

Authors:  Sanjib Kumar Upadhyay; Ashok Kumar Jha; S C Mishra
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2004-10

6.  Vitamin A supplementation in preschool children and risk of hearing loss as adolescents and young adults in rural Nepal: randomised trial cohort follow-up study.

Authors:  Jane Schmitz; Keith P West; Subarna K Khatry; Lee Wu; Steven C Leclerq; Sureswor L Karna; Joanne Katz; Alfred Sommer; Joseph Pillion
Journal:  BMJ       Date:  2012-01-10

7.  A study protocol for a cluster randomised trial for the prevention of chronic suppurative otitis media in children in Jumla, Nepal.

Authors:  Susan Clarke; Robyn Richmond; Heather Worth; Rajendra Raj Wagle
Journal:  BMC Ear Nose Throat Disord       Date:  2015-09-29

8.  Study of Various Prognostic Factors Affecting Successful Myringoplasty in a Tertiary Care Centre.

Authors:  Kripa Dangol; Rakesh Prasad Shrivastav
Journal:  Int Arch Otorhinolaryngol       Date:  2016-11-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.